A Message From Your Friends At The Southeast AETC: Our hearts go out to those in our community who were affected by the hurricanes. If you have patients that are having trouble accessing HIV services during this time, we urge you to utilize HRSA’s Find a Ryan White Provider tool to help navigate them to services nearby.

Participant Login
View Events Calendar

Hepatitis C (HCV) Toolkit

Hepatitis C Virus (HCV)

Hepatitis C is a liver infection caused by the hepatitis C virus (HCV). Hepatitis C is a blood-borne virus. Today, most people become infected with the hepatitis C virus by sharing needles or other equipment to inject drugs. For some people, hepatitis C is a short-term illness but for more than 50% of people who become infected with the hepatitis C virus, it becomes a long-term, chronic infection. Chronic hepatitis C is a serious disease than can result in long-term health problems, even death. Many people might not be aware of their infection because they are not clinically ill. There is no vaccine for hepatitis C. The best way to prevent hepatitis C is by avoiding behaviors that can spread the disease, especially injecting drugs. Resources for both providers and patients can be located on this page below. 

Slides

Helpful Links

The purpose of this training is to improve providers’ capacity to screen, medically manage, and provide advanced care for patients with Hepatitis C virus.

Helpful Links
Quick Fact Sheets
TitleDate
Webinar: HIV/HCV/HBV Co-infection2023/10/182023-10-18 10:50:53
Webinar: Hepatitis A-E2023/03/082023-03-08 10:50:35
Webinar: HIV/HBV/HCV co-infection2022/05/252022-05-25 10:00:58
Webinar: Emergency Department Testing Unmasks the Hidden Faces of the HCV Epidemic & Identifies Communities at Risk for an Outbreak of HIV Among Persons Who Inject Drugs2021/12/012021-12-01 07:00:00
Webinar: HCV and HIV Co-infection2020/10/072020-10-07 16:58:51
Webinar: HCV Basics and Testing2020/09/152020-09-15 16:00:00
Webinar: Primary Care for People with HIV2020/08/272020-08-27 15:43:00
Webinar: Infectious Diseases Associated with Injection Drug Use2020/08/122020-08-12 10:00:00
Webinar: C YA: SPNS Program at the Philadelphia Dept, of Public Health – How Close Did We Get to Ending Hep C in PLWH & What Will It Take to Get There?2020/03/042020-03-04 11:00:00
Webinar: Harm Reduction Initiative in KY: Lessons Learned2019/11/062019-11-06 11:00:10
Webinar: Viral Hepatitis in People Living with HIV: A Case-based Primer2019/10/302019-10-30 07:00:53
Webinar: The Ryan White Program Opiate Epidemic Response in WV2019/10/232019-10-23 10:00:23
Webinar: Hepatitis C Virus2019/10/162019-10-16 11:00:50
Webinar: HIV, HCV and Infection Prevention – Considerations for the Care of Persons Who Inject Drugs2019/06/212019-06-21 09:00:34
Webinar: Treating HCV Infection in 2019: It Doesn’t Get Much Better Than This2019/05/172019-05-17 09:00:11
Webinar: Screening, Testing and Diagnosis of HCV2019/04/192019-04-19 11:18:51
Webinar: HIV and Oral Health – Oral HPV Hepatitis C Updates2019/04/102019-04-10 10:00:19
Webinar: Barriers to HCV Care Among Persons of Color2019/03/152019-03-15 10:00:00
Webinar: Hepatitis C – Linkage and Treatment in Primary Care and Rural Health Settings2019/02/152019-02-15 07:00:13
Webinar: Initial Evaluation and Follow Up for Patients with Hepatitis C2018/10/102018-10-10 12:00:08
Webinar: Primary Care Guidelines for the Management of Persons Living with HIV2018/08/012018-08-01 08:00:06
Webinar: Hepatitis C: Looking to the Future2017/10/252017-10-25 07:38:39
Webinar: Hepatitis C Update: What’s New in 20172017/10/182017-10-18 07:57:45
Webinar: HIV/HCV Coinfection: Why It Matters and What To Do About It2016/10/262016-10-26 11:30:15
Webinar: From Prescription to Patient: Navigating Barriers to HCV Treatment Initiation2016/10/192016-10-19 10:51:20
Webinar: HCV Treatment in 2016: Genotypes 1, 2, and 32016/10/122016-10-12 10:06:28
Webinar: HCV Pretreatment Evaluation2016/10/052016-10-05 12:34:13
Webinar: Watch Out! Drug Drug Interactions with Antiretrovirals2016/07/202016-07-20 09:00:49
Webinar: HIV and Incarceration: Dual Epidemics2016/07/062016-07-06 12:33:21

Dr. Cody Chastain graduated from Loma Linda University School of Medicine in Loma Linda, CA in 2008 and was awarded the Chancellor’s Award as the top overall graduate. He trained and completed his training in Internal Medicine in 2011 at Duke University Medical Center in Durham, NC, where he was awarded the Haskel Schiff Award for excellence in the practice of clinical medicine. After working as a hospitalist for Duke University Health Systems, Dr. Chastain completed subspecialty training in the Division of Infectious Diseases at Vanderbilt University Medical Center, where he also served as chief fellow. He joined the faculty as an assistant professor in 2014 and currently leads the division’s Viral Hepatitis Program. He is an active educator in the Vanderbilt University School of Medicine and has received the Hugh J. Morgan Teaching Award and the William Schaffner Teaching Award for resident and fellow education. He currently serves as the Viral Hepatitis Project Director for the SE AETC.

The field of Hepatitis C Virus (HCV) treatment is changing at an extremely rapid pace with the advent of highly effective directly-acting agents (DAAs); the challenges of treating co-infected patients are significant. Although the primary mission of any AETC is focused on HIV/AIDS, viral hepatitis is increasingly important both independent of and related to HIV. In the U.S., approximately 730,000 people are chronically infected with hepatitis B virus (HBV), while over 2.7 million people are chronically infected with hepatitis C virus (HCV). To augment provider education in this arena, we actively incorporated viral hepatitis education into both live and web-based programming for HIV providers, trainees, and other healthcare providers. Cody Chastain, MD, a speaker for the TN AETC, Vanderbilt University, and the Tennessee Department of Health (TDH) presents on this topic weekly and has championed HCV education for providers across the state.